Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus

Diabetologia

Volumn 42, Issue 5, 1999, Pages 589-595

  Rudberg, S ^a,e   Osterby R ^b   Bangstad, H J ^c   Dahlquist, G ^d   Persson, B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b University Institute of Pathology Arhus   (Denmark)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiotensin converting enzyme inhibitor; Beta receptor blocker; Diabetic glomerulopathy; Microalbuminuria; Type I diabetes

Indexed keywords

ALBUMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HEMOGLOBIN A1C; METOPROLOL;

ADOLESCENT; ADULT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS BASEMENT MEMBRANE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BIOPSY; MALE; MESANGIUM; MICROALBUMINURIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032967512     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051199     Document Type: Article

References (22)

1. Mathiesen ER, Hommel E, Giese J, Parving H-H (1991) Efficacy of captopril postponing nephropathy in normotensive insulin-dependent diabetics with microalbuminuria. BMJ 330: 81-87
2. The EUCLID study group (1997) Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 349: 1787-1792
3. Björck S, Mulec H, Johnsen SA, Norden G, Aurell M (1992) Renal protective effect of enalapril in diabetic nephropathy. BMJ 304: 339-342
4. Elving LD, Wetzels JMF, van Lier HJJ, de Nobel E, Berden JHM (1994) Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Diabetologia 37: 604-609
5. Sawicki PT, for the Diabetes Teaching and Treatment Programmes Working Group (1997). Stabilization of glomerular filtration rate over 2 years in patients with diabetic nephropathy under intensified therapy regimens. Nephrol Dial Transplant 12: 1890-1899
6. Mogensen CE, Chacati A, Christensen CK et al. (1985-1986) Microalbuminuria: An early marker of renal involvement in diabetes. Uremia Invest 9: 85-95
7. Rudberg S, Dahlquist G (1994) Determinants of progression in microalbuminuria in IDDM adolescents. Diabetes Care 19: 369-371
8. Rudberg S, Österby R (1997) Decreased glomerular filtration rate - an indicator of more advanced diabetic glomerulopathy in the early course of microalbuminuria in IDDM adolescents? Nephrol Dial Transplant 12: 1149-1154
9. Morelli E, Loon N, Meyer T, Peters W, Myers BD (1990). Effects of converting enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 39: 76-82
10. Cooper ME, Allen TJ, Macmillan PA, Clarke BE, Jerums G, Doyle AE (1989) Enalapril retards basement membrane thickening and albuminuria in the diabetic rat. Diabetologia 32: 326-328
11. Perico N, Amuschastegui CS, Malanchini B, Bertini T, Remuzzi G (1994) Angiotensin converting enzyme inhibition and calcium channel blockade normalise early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage. Exp Nephrol 2: 220-228
12. Taft JL, Nolan CH, Yeung SP, Hewitson TD, Martin IR (1994) Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria. Diabetes 43: 1046-1051
13. Bangstad H-J, Österby R, Dahl-Jörgensen K, Berg KJ, Hartmann A, Hanssen KF (1994) Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 37: 483-490
14. Maunsbach AB (1966) The influence of different fixatives and fixation methods on the ultrastucture of rat kidney proximal tubule cells. Effects of varying osmolality, ionic strength, buffer system and fixative concentration of glutaraldehyd solutions. J Ultrastruct Res 15: 283-309
15. Teppo AM (1982) Immunoturbidimetri of albumin and immunoglobulin in urine. Clin Chem 28: 1359-1361
16. Hilger HH, Klumper SD, Ullrich J (1958) Mikroanalytische Untersuchungen über die Wasser- und Natriumrückresorption aus den Sammelrohrzellen der Säugetierniere. Pflugers Arch 267: 218-237
17. Smith HW, Finkelstein N, Aliminosa L, Crawford B, Graber M (1945) The renal clearances of substituted hippuric acid and derivates and other aromatic acids in dog and man. J Clin Invest 24: 388-401
18. Hirose K, Österby R, Nozawa M, Gundersen HJ (1982) Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int 21: 889-895
19. Walker JD, Close CF, Jones SL et al. (1992). Glomerular structure in type 1 (insulin-dependent) diabetic patients with normo-and microalbuminuria. Kidney Int 41: 741-748
20. Snedecor GW, Cochran WG (1980) Comparisons of two samples In: Snedecor and Cochran (ed) Statistical Methods. 7th edn. Ames, Iowa State U.P. pp 111-114
21. Rudberg S, Aperia A, Freyschuss U, Persson B (1990). Enalapril reduces microalbuminuria in young normotensive type 1 (insulindependent) diabetic patients irrespective of its hypotensive effect. Diabetologia 33: 470-476
22. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462